Go Pro
→ Your book is inside (From Profits Run) (Ad)tc pixel Free MCHX Stock Alerts

Marchex (MCHX) Financials

Marchex logo
$1.81 +0.01 (+0.56%)
Closing price 04:00 PM Eastern
Extended Trading
$1.82 +0.01 (+0.55%)
As of 04:21 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for Marchex

Annual Income Statements for Marchex

This table shows Marchex's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 27 -84 -6.44 -2.68 -4.04 -38 -4.39 -8.25 -9.91 -4.95 -5.24
Consolidated Net Income / (Loss)		 27 -84 -6.09 -2.68 -4.04 -38 -4.39 -8.25 -9.91 -4.95 -5.24
Net Income / (Loss) Continuing Operations		 -0.60 -84 -6.09 -2.68 -9.73 -42 -4.39 -8.25 -9.91 -4.95 -5.24
Total Pre-Tax Income 		-0.57 -84 -6.05 -2.83 -13 -44 -4.16 -8.06 -9.82 -4.57 -5.16
Total Operating Income		 -2.00 -84 -6.36 -3.89 -14 -44 -12 -8.15 -9.64 -4.45 -5.72
Total Gross Profit		 64 53 41 37 36 30 32 32 29 31 29
Total Revenue		 143 130 90 85 54 51 53 52 50 48 45
Operating Revenue		 143 130 90 85 54 51 53 52 50 48 45
Total Cost of Revenue		 79 77 49 48 18 21 22 20 21 17 17
Operating Cost of Revenue		 79 77 49 48 18 21 22 20 21 17 17
Total Operating Expenses		 66 136 47 41 50 74 44 40 39 35 34
Selling, General & Admin Expense		 19 22 14 11 13 13 9.29 9.79 10 10 11
Marketing Expense		 16 22 16 14 14 17 14 14 11 12 13
Research & Development Expense		 31 28 18 15 18 21 16 14 15 12 9.75
Amortization Expense		 - - - 0.78 6.26 5.33 4.48 2.12 1.99 0.60 0.00
Other Operating Expenses / (Income)		 0.22 0.66 - 0.46 -0.45 -1.04 0.14 0.07 0.01 0.00 1.35
Total Other Income / (Expense), net		 1.43 -0.12 0.32 1.05 0.75 0.12 7.64 0.09 -0.17 -0.12 0.57
Interest Expense		 - - - - - 0.00 -5.19 -0.09 0.17 0.12 -0.57
Income Tax Expense		 0.03 0.05 0.04 -0.16 -3.48 -1.92 0.23 0.18 0.09 0.38 0.08
Basic Earnings per Share		 - - - ($0.12) ($0.18) ($1.66) ($0.10) ($0.38) ($0.23) ($0.11) ($0.12)
Weighted Average Basic Shares Outstanding		 41.10M 43.10M 43.82M 42.10M 45.46M 46.26M 0.00 43.22M 42.62M 43.16M 43.86M
Diluted Earnings per Share		 - - - ($0.12) ($0.18) ($1.66) ($0.10) ($0.38) ($0.23) ($0.11) ($0.12)
Weighted Average Diluted Shares Outstanding		 41.10M 43.10M 43.82M 42.10M 50.25M 50.92M 0.00 47.88M 47.28M 47.82M 48.52M
Weighted Average Basic & Diluted Shares Outstanding		 41.10M 43.10M 43.82M 42.10M 44.42M 41.31M 42.27M 43.24M 43.66M 43.71M 43.91M

Quarterly Income Statements for Marchex

This table shows Marchex's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders		 -1.55 -1.14 -1.45 -0.76 -0.83 -1.91 -1.98 0.09 -1.02 -2.32 -1.72
Consolidated Net Income / (Loss)		 -1.55 -1.14 -1.45 -0.76 -0.83 -1.91 -1.98 0.09 -1.02 -2.32 -1.72
Net Income / (Loss) Continuing Operations		 -1.55 -1.14 -1.45 -0.76 -0.83 -1.91 -1.98 0.09 -1.02 -2.32 -1.72
Total Pre-Tax Income 		-1.54 -1.10 -1.39 -0.75 -0.81 -1.62 -1.87 0.09 -0.99 -2.38 -1.53
Total Operating Income		 -1.32 -1.12 -1.31 -0.72 -0.83 -1.59 -1.87 -0.54 -0.94 -2.38 -1.35
Total Gross Profit		 7.72 7.71 7.16 7.92 8.33 7.54 7.21 7.59 7.27 6.64 6.42
Total Revenue		 13 12 12 12 13 12 11 12 12 11 11
Operating Revenue		 13 12 12 12 13 12 11 12 12 11 11
Total Cost of Revenue		 5.06 4.68 4.41 4.15 4.22 4.38 4.19 4.07 4.25 4.21 4.20
Operating Cost of Revenue		 5.06 4.68 4.41 4.15 4.22 4.38 4.19 4.07 4.25 4.21 4.20
Total Operating Expenses		 9.04 8.83 8.47 8.64 9.15 9.13 9.08 8.12 8.21 9.01 7.77
Selling, General & Admin Expense		 2.25 2.79 2.29 2.53 2.67 2.76 3.15 2.46 2.93 2.27 2.11
Marketing Expense		 2.32 2.49 2.79 2.74 3.22 3.38 3.27 3.17 2.91 3.19 3.26
Research & Development Expense		 3.94 3.15 3.25 3.22 3.11 2.84 2.67 2.50 2.37 2.21 2.41
Amortization Expense		 0.53 0.39 0.15 0.15 0.15 0.15 0.00 0.00 0.00 - 0.00
Total Other Income / (Expense), net		 -0.22 0.02 -0.08 -0.03 0.02 -0.03 -0.00 0.63 -0.05 -0.00 -0.17
Interest Expense		 - - 0.08 0.03 - - 0.00 -0.63 0.05 0.00 0.17
Income Tax Expense		 0.01 0.04 0.06 0.00 0.03 0.29 0.11 0.01 0.03 -0.06 0.20
Basic Earnings per Share		 ($0.04) ($0.02) ($0.03) ($0.02) ($0.02) ($0.04) ($0.05) $0.00 ($0.02) ($0.05) ($0.04)
Weighted Average Basic Shares Outstanding		 42.76M 42.62M 43.05M 43.06M 43.20M 43.16M 43.72M 43.90M 43.91M 43.86M 43.96M
Diluted Earnings per Share		 ($0.04) ($0.02) ($0.03) ($0.02) ($0.02) ($0.04) ($0.05) $0.00 ($0.02) ($0.05) ($0.04)
Weighted Average Diluted Shares Outstanding		 47.43M 47.28M 47.72M 47.73M 47.86M 47.82M 48.38M 48.56M 48.57M 48.52M 48.62M
Weighted Average Basic & Diluted Shares Outstanding		 43.32M 43.66M 43.68M 43.68M 43.68M 43.71M 43.90M 44.18M 43.91M 43.91M 44.30M

Annual Cash Flow Statements for Marchex

This table details how cash moves in and out of Marchex's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 29 -5.21 0.24 -59 -2.70 -7.88 -6.77 -6.61 -5.87 -1.84 -2.83
Net Cash From Operating Activities		 13 -3.67 1.69 5.05 5.09 -3.37 -6.34 -2.29 -4.40 -1.10 -1.41
Net Cash From Continuing Operating Activities		 13 -3.67 1.69 5.05 -0.84 -7.01 -6.34 -2.29 -4.40 -1.10 -1.41
Net Income / (Loss) Continuing Operations		 27 -84 -6.09 -2.68 -9.73 -42 -4.39 -8.25 -9.91 -4.95 -5.24
Consolidated Net Income / (Loss)		 27 -84 -6.09 -2.68 -4.04 -38 -4.39 -8.25 -9.91 -4.95 -5.24
Depreciation Expense		 3.66 3.19 2.79 2.60 8.13 7.25 5.97 4.03 3.87 2.65 2.67
Non-Cash Adjustments To Reconcile Net Income		 -13 75 4.82 3.44 3.39 25 -2.14 3.55 3.21 1.56 3.20
Changes in Operating Assets and Liabilities, net		 -4.28 2.03 0.17 1.69 -2.62 3.01 -5.79 -1.63 -1.57 -0.36 -2.05
Net Cash From Investing Activities		 22 -1.22 -1.58 -37 -9.68 0.98 -0.95 -2.87 -1.31 -0.43 -1.32
Net Cash From Continuing Investing Activities		 22 -1.22 -1.58 -37 -9.60 0.98 -0.95 -2.87 -1.31 -0.43 -1.32
Purchase of Property, Plant & Equipment		 -4.11 -0.99 -1.58 -1.65 -1.62 -1.35 -1.35 -2.87 -1.38 -0.43 -1.48
Other Investing Activities, net		 - - - -0.58 -0.06 2.25 - - - 0.00 0.16
Net Cash From Financing Activities		 -5.45 -0.31 0.13 -27 1.89 -5.49 0.53 -1.46 -0.16 -0.31 -0.10
Net Cash From Continuing Financing Activities		 -5.45 -0.31 0.13 -27 1.89 -5.65 0.53 -1.46 -0.16 -0.31 -0.10
Repayment of Debt		 - - - - - - - - -0.19 -0.31 -0.40
Issuance of Common Equity		 0.34 0.35 0.13 0.14 1.89 0.08 0.53 0.04 0.03 0.00 0.30
Cash Interest Paid		 - - - 1.07 - - - - 0.12 0.12 0.08
Cash Income Taxes Paid		 -0.03 -0.02 0.02 -0.05 0.03 - -0.17 0.06 0.07 0.06 0.05

Quarterly Cash Flow Statements for Marchex

This table details how cash moves in and out of Marchex's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents		 -0.41 0.89 -2.58 -0.06 0.10 0.69 -2.75 0.47 -0.17 -0.38 -0.92
Net Cash From Operating Activities		 -0.38 1.75 -2.48 0.12 0.38 0.88 -2.62 0.80 0.29 0.12 -0.51
Net Cash From Continuing Operating Activities		 -0.38 1.75 -2.48 0.12 0.38 0.88 -2.62 0.80 0.29 0.12 -0.51
Net Income / (Loss) Continuing Operations		 -1.55 -1.14 -1.45 -0.76 -0.83 -1.91 -1.98 0.09 -1.02 -2.32 -1.72
Consolidated Net Income / (Loss)		 -1.55 -1.14 -1.45 -0.76 -0.83 -1.91 -1.98 0.09 -1.02 -2.32 -1.72
Depreciation Expense		 1.28 0.75 0.47 0.67 0.73 0.77 0.63 1.15 0.19 0.70 0.72
Non-Cash Adjustments To Reconcile Net Income		 0.65 0.90 0.46 0.34 0.35 0.41 0.40 -0.07 1.04 1.83 0.71
Changes in Operating Assets and Liabilities, net		 -0.77 1.25 -1.96 -0.14 0.14 1.60 -1.67 -0.37 0.08 -0.09 -0.22
Net Cash From Investing Activities		 0.06 -0.85 -0.00 -0.08 -0.18 -0.17 -0.29 -0.25 -0.35 -0.43 -0.41
Net Cash From Continuing Investing Activities		 0.06 -0.85 -0.00 -0.08 -0.18 -0.17 -0.29 -0.25 -0.35 -0.43 -0.41
Purchase of Property, Plant & Equipment		 -0.00 -0.85 -0.00 -0.08 -0.18 -0.17 -0.29 -0.35 -0.38 -0.46 -0.44
Other Investing Activities, net		 - - - - - - 0.00 - 0.03 0.03 0.03
Net Cash From Financing Activities		 -0.09 -0.01 -0.09 -0.10 -0.10 -0.02 0.16 -0.08 -0.11 -0.07 0.00
Net Cash From Continuing Financing Activities		 -0.09 -0.01 -0.09 -0.10 -0.10 -0.02 0.16 -0.08 -0.11 -0.07 0.00
Repayment of Debt		 -0.10 -0.01 -0.09 -0.10 -0.10 -0.02 -0.10 - - - 0.00
Issuance of Common Equity		 0.01 0.00 0.00 - - 0.00 0.27 0.03 - 0.00 0.00
Cash Interest Paid		 0.04 0.03 0.03 0.04 0.03 0.03 0.03 0.02 0.10 -0.07 0.01
Cash Income Taxes Paid		 0.01 - 0.00 0.07 - -0.00 0.00 0.05 0.01 -0.01 0.01

Annual Balance Sheets for Marchex

This table presents Marchex's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 205 128 124 113 125 77 66 57 47 43 40
Total Current Assets		 136 125 121 64 62 42 38 31 24 22 19
Cash & Equivalents		 109 104 104 45 42 34 27 20 15 13 9.94
Accounts Receivable		 25 19 15 16 7.53 6.33 8.02 8.40 7.39 7.07 6.67
Prepaid Expenses		 1.78 1.63 2.04 2.66 2.02 2.16 2.41 2.02 1.81 0.70 1.01
Other Current Assets		 - - - - - - - - - 1.74 1.42
Plant, Property, & Equipment, net		 5.78 3.56 2.41 2.92 3.00 2.75 2.82 4.05 2.40 1.81 1.85
Total Noncurrent Assets		 64 0.21 0.33 46 59 32 25 22 21 19 19
Goodwill		 63 - 0.00 24 32 18 18 18 18 18 18
Other Noncurrent Operating Assets		 0.22 0.21 0.33 0.92 6.11 5.09 3.22 1.71 3.11 1.55 1.23
Total Liabilities & Shareholders' Equity		 205 128 124 113 125 77 66 57 47 43 40
Total Liabilities		 18 15 34 18 25 24 14 13 12 11 9.60
Total Current Liabilities		 17 15 33 15 18 21 13 12 9.72 9.27 8.07
Accounts Payable		 9.46 6.81 4.93 5.97 0.62 2.42 1.36 2.04 1.53 1.35 3.20
Accrued Expenses		 6.71 7.71 5.59 5.82 4.17 4.21 3.87 3.83 3.22 4.20 2.74
Current Deferred Revenue		 0.69 0.35 0.31 - 0.87 1.39 2.02 1.38 1.21 1.09 0.60
Current Employee Benefit Liabilities		 - - - - 2.69 5.98 3.63 3.57 3.29 2.13 1.18
Other Current Liabilities		 - - - 1.78 1.50 1.83 1.79 1.25 0.46 0.50 0.36
Total Noncurrent Liabilities		 0.66 0.13 1.09 3.26 7.12 3.29 1.65 0.62 1.89 1.30 1.53
Noncurrent Deferred & Payable Income Tax Liabilities		 - - - 1.53 0.98 0.16 0.19 0.23 0.25 0.58 0.66
Other Noncurrent Operating Liabilities		 0.66 0.13 1.09 1.73 6.14 3.14 1.47 0.39 1.64 0.72 0.87
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 187 113 90 95 100 53 52 44 36 33 30
Total Preferred & Common Equity		 187 113 90 95 100 53 52 44 36 33 30
Total Common Equity		 187 113 90 95 100 53 52 44 36 33 30
Common Stock		 351 360 343 351 360 351 355 355 357 359 361
Retained Earnings		 -164 -248 -254 -256 -260 -299 -303 -311 -321 -326 -331

Quarterly Balance Sheets for Marchex

This table presents Marchex's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets		 49 46 46 44 41 42 41 39
Total Current Assets		 24 22 22 22 20 21 20 18
Cash & Equivalents		 14 12 12 12 10 10 10 9.02
Accounts Receivable		 8.13 8.15 7.64 7.76 7.58 7.56 7.40 6.83
Prepaid Expenses		 2.11 2.30 2.87 1.97 2.32 3.04 2.69 1.07
Other Current Assets		 - 0.00 0.00 0.00 0.00 0.00 - 1.23
Plant, Property, & Equipment, net		 3.31 2.09 1.86 2.07 1.72 1.74 1.72 1.98
Total Noncurrent Assets		 22 21 21 20 19 19 19 18
Goodwill		 18 18 18 18 18 18 18 18
Other Noncurrent Operating Assets		 3.26 3.00 3.30 2.49 1.43 1.60 1.46 0.87
Total Liabilities & Shareholders' Equity		 49 46 46 44 41 42 41 39
Total Liabilities		 12 11 11 9.96 9.26 9.94 9.20 9.69
Total Current Liabilities		 9.81 9.02 9.47 8.66 7.97 8.73 8.07 8.19
Accounts Payable		 1.18 1.46 1.92 1.20 1.71 2.92 2.64 2.99
Accrued Expenses		 3.76 3.61 3.45 3.47 3.92 3.68 3.63 3.27
Current Deferred Revenue		 1.21 1.92 1.47 0.86 1.29 0.81 0.43 0.70
Current Employee Benefit Liabilities		 2.99 1.57 2.14 2.64 0.59 0.99 1.03 0.86
Other Current Liabilities		 0.67 0.47 0.49 0.50 0.46 0.33 0.34 0.37
Total Noncurrent Liabilities		 1.99 1.71 1.50 1.30 1.29 1.21 1.14 1.51
Noncurrent Deferred & Payable Income Tax Liabilities		 0.23 0.28 0.28 0.29 0.66 0.66 0.68 0.80
Other Noncurrent Operating Liabilities		 1.76 1.44 1.22 1.01 0.64 0.55 0.46 0.71
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 37 35 35 34 31 32 32 29
Total Preferred & Common Equity		 37 35 35 34 31 32 32 29
Total Common Equity		 37 35 35 34 31 32 32 29
Common Stock		 357 358 358 358 360 360 361 362
Retained Earnings		 -320 -323 -323 -324 -328 -328 -329 -333

Annual Metrics And Ratios for Marchex

This table displays calculated financial ratios and metrics derived from Marchex's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding		 42,065,021.00 43,158,580.00 43,669,270.00 41,982,765.00 43,094,400.00 39,570,611.00 41,552,410.00 42,463,056.00 43,316,764.00 43,682,345.00 43,906,261.00
DEI Adjusted Shares Outstanding		 42,065,021.00 43,158,580.00 43,669,270.00 41,982,765.00 43,094,400.00 39,570,611.00 41,552,410.00 42,463,056.00 43,316,764.00 43,682,345.00 43,906,261.00
DEI Earnings Per Adjusted Shares Outstanding		 0.63 -1.95 -0.15 -0.06 -0.09 -0.97 -0.11 -0.19 -0.23 -0.11 -0.12
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -17.62% -9.42% -30.30% -5.58% -36.08% -6.00% 4.41% -2.44% -4.33% -3.58% -5.61%
EBITDA Growth		 -20.64% -2,714.62% 95.58% 63.87% -352.33% -530.85% 84.17% 29.35% -40.18% 68.79% -69.35%
EBIT Growth		 -171.43% -14,638.95% 92.43% 38.88% -259.05% -215.60% 73.23% 30.92% -18.33% 53.88% -28.72%
NOPAT Growth		 -802.25% -4,088.57% 92.42% 38.88% -259.05% -215.60% 73.23% 30.92% -18.33% 53.88% -28.72%
Net Income Growth		 239.97% -414.61% 92.76% 56.00% -50.93% -851.16% 88.58% -87.81% -20.19% 50.08% -5.82%
EPS Growth		 0.00% 0.00% 0.00% 0.00% -50.00% -822.22% 93.98% -280.00% 39.47% 52.17% -9.09%
Operating Cash Flow Growth		 -43.12% -128.77% 146.12% 198.52% 0.85% -166.22% -88.02% 63.86% -91.75% 74.88% -27.54%
Free Cash Flow Firm Growth		 -113.03% 385.69% -127.75% -1,515.54% 73.32% 89.42% -570.97% 43.46% 11.19% 60.78% -149.65%
Invested Capital Growth		 2.88% -88.10% -17.22% 560.96% 4.91% -55.22% 1.90% -3.19% -10.05% -6.57% 1.39%
Revenue Q/Q Growth		 4.44% -4.78% -6.77% 1.53% -45.87% 230.97% 0.19% -0.95% 0.20% -0.97% -2.31%
EBITDA Q/Q Growth		 10,758.62% -9.64% 57.50% 18.97% -382.29% 9.05% 37.13% -73.89% 25.83% -32.23% -39.59%
EBIT Q/Q Growth		 84.49% -8.97% 44.22% -11.82% -163.55% 8.34% 25.05% -27.03% 19.94% -11.71% -15.99%
NOPAT Q/Q Growth		 45.48% -6.96% 44.22% -11.82% -163.55% 8.34% 25.05% -27.03% 19.94% -11.71% -15.99%
Net Income Q/Q Growth		 2.65% -9.09% 46.35% -5.98% 5.23% -14.89% 43.38% -22.95% 19.70% -18.35% -8.45%
EPS Q/Q Growth		 0.00% 0.00% 0.00% 0.00% -20.00% -107.50% 0.00% 0.00% 52.08% -22.22% -9.09%
Operating Cash Flow Q/Q Growth		 -21.77% -73.07% 88.84% 24.35% -34.96% 10.86% 11.38% 0.99% 33.91% -390.67% -115.29%
Free Cash Flow Firm Q/Q Growth		 -50.12% 2.94% 26.28% -2,297.50% 70.19% 93.61% -61.97% 6.09% 31.87% -35.46% -40.98%
Invested Capital Q/Q Growth		 3.29% -14.77% 13.19% 709.27% 22.25% -21.31% -1.59% -7.54% -9.74% -9.85% -6.84%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 44.92% 40.59% 45.36% 43.93% 66.96% 59.22% 59.43% 60.78% 58.76% 64.32% 63.20%
EBITDA Margin		 2.16% -62.39% -3.95% -1.51% -10.71% -71.87% -10.89% -7.89% -11.56% -3.74% -6.72%
Operating Margin		 -1.40% -64.76% -7.05% -4.56% -25.62% -86.02% -22.06% -15.62% -19.32% -9.24% -12.60%
EBIT Margin		 -0.40% -64.85% -7.05% -4.56% -25.62% -86.02% -22.06% -15.62% -19.32% -9.24% -12.60%
Profit (Net Income) Margin		 18.68% -64.89% -6.74% -3.14% -7.42% -75.06% -8.21% -15.80% -19.86% -10.28% -11.53%
Tax Burden Percent		 -4,687.89% 100.06% 100.69% 94.50% 30.60% 87.51% 105.58% 102.28% 100.96% 108.32% 101.53%
Interest Burden Percent		 100.00% 100.00% 95.03% 72.89% 94.61% 99.72% 35.25% 98.92% 101.79% 102.70% 90.08%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 -1.82% -134.03% -52.27% -9.27% -18.70% -79.63% -34.14% -23.74% -30.07% -15.14% -20.03%
ROIC Less NNEP Spread (ROIC-NNEP)		 -31.55% -110.25% -50.52% -9.34% -31.38% -59.36% -48.00% -13.06% -12.05% -1.74% -9.21%
Return on Net Nonoperating Assets (RNNOA)		 17.37% 78.13% 46.28% 6.38% 14.55% 29.22% 25.71% 6.49% 5.29% 0.69% 3.34%
Return on Equity (ROE)		 15.55% -55.91% -5.99% -2.89% -4.15% -50.41% -8.43% -17.25% -24.78% -14.44% -16.69%
Cash Return on Invested Capital (CROIC)		 -4.65% 23.42% -33.43% -156.71% -23.49% -3.35% -36.02% -20.50% -19.49% -8.34% -21.41%
Operating Return on Assets (OROA)		 -0.30% -50.42% -5.05% -3.28% -11.75% -43.74% -16.53% -13.29% -18.50% -9.81% -13.81%
Return on Assets (ROA)		 13.86% -50.45% -4.83% -2.26% -3.40% -38.17% -6.15% -13.45% -19.01% -10.91% -12.63%
Return on Common Equity (ROCE)		 15.51% -55.75% -5.96% -2.89% -4.15% -50.41% -8.43% -17.25% -24.78% -14.44% -16.69%
Return on Equity Simple (ROE_SIMPLE)		 14.25% -74.22% -6.76% -2.82% -4.05% -72.97% -8.52% -18.69% -27.63% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -1.40 -59 -4.45 -2.72 -9.77 -31 -8.26 -5.70 -6.75 -3.11 -4.01
NOPAT Margin		 -0.98% -45.33% -4.93% -3.19% -17.93% -60.21% -15.44% -10.93% -13.52% -6.47% -8.82%
Net Nonoperating Expense Percent (NNEP)		 29.73% -23.78% -1.76% 0.07% 12.68% -20.26% 13.86% -10.68% -18.01% -13.40% -10.82%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - - -18.82% -9.54% -13.32%
Cost of Revenue to Revenue		 55.08% 59.41% 54.64% 56.07% 33.04% 40.78% 40.57% 39.22% 41.24% 35.68% 36.80%
SG&A Expenses to Revenue		 12.94% 16.79% 15.03% 12.76% 23.90% 24.98% 17.38% 18.76% 20.45% 21.29% 23.79%
R&D to Revenue		 21.72% 21.96% 20.04% 18.09% 32.81% 41.00% 30.13% 27.52% 30.77% 25.80% 21.46%
Operating Expenses to Revenue		 46.32% 105.35% 52.40% 48.49% 92.58% 145.24% 81.49% 76.40% 78.08% 73.56% 75.80%
Earnings before Interest and Taxes (EBIT)		 -0.57 -84 -6.36 -3.89 -14 -44 -12 -8.15 -9.64 -4.45 -5.72
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 3.09 -81 -3.57 -1.29 -5.84 -37 -5.83 -4.12 -5.77 -1.80 -3.05
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 0.75 0.86 1.34 1.17 1.63 1.47 2.00 1.54 1.64 2.34 2.42
Price to Tangible Book Value (P/TBV)		 1.13 0.86 1.34 2.23 3.39 2.99 3.53 2.84 3.33 5.07 5.82
Price to Revenue (P/Rev)		 0.98 0.75 1.33 1.31 2.99 1.51 1.93 1.30 1.18 1.59 1.60
Price to Earnings (P/E)		 5.23 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 2.41% 0.00% 0.00% 18.87% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 19.12% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.39 0.00 2.09 1.32 2.26 2.04 3.11 2.01 2.08 3.21 3.12
Enterprise Value to Revenue (EV/Rev)		 0.21 0.00 0.18 0.79 2.22 0.95 1.42 0.91 0.89 1.32 1.39
Enterprise Value to EBITDA (EV/EBITDA)		 9.84 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 2.38 0.00 9.53 13.31 23.79 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.01 0.00 0.10 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 -0.55 -0.71 -0.92 -0.68 -0.46 -0.49 -0.54 -0.50 -0.44 -0.40 -0.36
Leverage Ratio		 1.12 1.11 1.24 1.28 1.22 1.32 1.37 1.28 1.30 1.32 1.32
Compound Leverage Factor		 1.12 1.11 1.18 0.93 1.15 1.32 0.48 1.27 1.33 1.36 1.19
Debt to Total Capital		 0.00% 0.00% 0.00% 1.25% 0.00% 8.86% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 1.25% 0.00% 8.86% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 99.77% 99.62% 99.51% 98.75% 100.00% 91.14% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA		 0.00 0.00 0.00 -0.93 0.00 -0.14 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 0.00 0.00 0.00 34.13 0.00 0.78 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.00 0.00 0.00 -0.44 0.00 -0.17 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 0.00 0.00 0.00 16.18 0.00 0.93 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 5.05 1.07 0.68 1.69 1.54 -4.41 -1.46 -3.62 -5.69 -5.09 -6.13
Noncontrolling Interest Sharing Ratio		 0.25% 0.28% 0.43% 0.24% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 8.05 8.37 3.70 4.34 3.56 2.02 2.96 2.56 2.45 2.40 2.36
Quick Ratio		 7.93 8.26 3.64 4.16 2.81 1.92 2.77 2.39 2.26 2.14 2.06
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -3.59 10 -2.85 -46 -12 -1.30 -8.71 -4.93 -4.38 -1.72 -4.28
Operating Cash Flow to CapEx		 310.52% -372.11% 107.29% 305.94% 313.86% -249.30% -469.43% -80.00% -334.98% -257.34% -95.20%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -25.29 -14.30 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -25.40 -9.20 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -32.99 -12.78 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.74 0.78 0.72 0.72 0.46 0.51 0.75 0.85 0.96 1.06 1.10
Accounts Receivable Turnover		 5.66 5.95 5.35 5.49 4.59 7.39 7.45 6.36 6.32 6.65 6.61
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 25.52 27.76 30.29 32.01 18.42 17.84 19.22 15.19 15.48 22.87 24.79
Accounts Payable Turnover		 6.78 9.46 8.41 8.77 5.47 13.73 11.46 12.04 11.53 11.92 7.35
Days Sales Outstanding (DSO)		 64.52 61.34 68.28 66.49 79.46 49.37 48.98 57.43 57.74 54.86 55.22
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 53.81 38.58 43.42 41.60 66.76 26.58 31.86 30.32 31.66 30.63 49.65
Cash Conversion Cycle (CCC)		 10.71 22.76 24.86 24.89 12.69 22.79 17.12 27.11 26.08 24.23 5.57
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 78 9.32 7.72 51 54 24 24 24 21 20 20
Invested Capital Turnover		 1.85 2.96 10.60 2.90 1.04 1.32 2.21 2.17 2.22 2.34 2.27
Increase / (Decrease) in Invested Capital		 2.19 -69 -1.61 43 2.50 -30 0.46 -0.78 -2.38 -1.40 0.28
Enterprise Value (EV)		 30 -6.40 16 67 121 49 76 47 44 64 63
Market Capitalization		 140 98 120 111 163 78 103 68 59 76 73
Book Value per Share		 $4.45 $2.61 $2.05 $2.26 $2.32 $1.33 $1.24 $1.04 $0.83 $0.75 $0.69
Tangible Book Value per Share		 $2.94 $2.61 $2.05 $1.19 $1.11 $0.66 $0.70 $0.56 $0.41 $0.35 $0.29
Total Capital		 187 113 90 96 100 58 52 44 36 33 30
Total Debt		 0.00 0.00 0.00 1.20 0.00 5.12 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 -109 -104 -104 -44 -42 -29 -27 -20 -15 -13 -9.94
Capital Expenditures (CapEx)		 4.11 0.99 1.58 1.65 1.62 1.35 1.35 2.87 1.31 0.43 1.48
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 9.67 5.68 -16 5.29 3.14 -7.34 -2.25 -1.65 -0.52 0.24 1.03
Debt-free Net Working Capital (DFNWC)		 119 110 88 51 45 27 25 19 14 13 11
Net Working Capital (NWC)		 119 110 88 49 45 21 25 19 14 13 11
Net Nonoperating Expense (NNE)		 -28 25 1.63 -0.04 -5.73 7.61 -3.87 2.54 3.16 1.83 1.23
Net Nonoperating Obligations (NNO)		 -109 -104 -82 -44 -46 -29 -27 -20 -15 -13 -9.94
Total Depreciation and Amortization (D&A)		 3.66 3.19 2.79 2.60 8.13 7.25 5.97 4.03 3.87 2.65 2.67
Debt-free, Cash-free Net Working Capital to Revenue		 6.76% 4.39% -17.53% 6.20% 5.77% -14.33% -4.20% -3.17% -1.04% 0.51% 2.27%
Debt-free Net Working Capital to Revenue		 83.09% 84.63% 97.86% 59.26% 82.35% 51.77% 46.45% 36.08% 28.22% 27.04% 24.16%
Net Working Capital to Revenue		 83.09% 84.63% 97.86% 57.84% 82.35% 41.76% 46.45% 36.08% 28.22% 27.04% 24.16%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.65 ($2.01) $0.00 $0.00 ($0.18) ($1.66) ($0.20) ($0.19) $0.00 ($0.11) ($0.12)
Adjusted Weighted Average Basic Shares Outstanding		 41.97M 43.10M 43.82M 42.10M 44.42M 46.26M 43.92M 43.22M 42.62M 43.16M 43.86M
Adjusted Diluted Earnings per Share		 $0.65 ($2.01) $0.00 $0.00 ($0.18) ($1.66) ($0.20) ($0.19) $0.00 ($0.11) ($0.12)
Adjusted Weighted Average Diluted Shares Outstanding		 41.97M 43.10M 43.82M 42.10M 44.42M 50.92M 48.58M 47.88M 47.28M 47.82M 48.52M
Adjusted Basic & Diluted Earnings per Share		 $0.65 ($2.01) $0.00 $0.00 ($0.18) ($1.66) ($0.20) $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 41.97M 43.10M 43.82M 42.10M 44.42M 41.31M 42.27M 43.24M 43.66M 43.71M 43.91M
Normalized Net Operating Profit after Tax (NOPAT)		 -1.40 -14 -4.45 -2.72 -9.77 -17 -8.26 -5.70 -6.75 -3.11 -4.01
Normalized NOPAT Margin		 -0.98% -11.13% -4.93% -3.19% -17.93% -33.36% -15.44% -10.93% -13.52% -6.47% -8.82%
Pre Tax Income Margin		 -0.40% -64.85% -6.70% -3.32% -24.24% -85.78% -7.78% -15.45% -19.67% -9.49% -11.35%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -55.74 -37.06 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -39.02 -25.94 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -63.32 -40.63 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -46.60 -29.52 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 6.31% 0.00% 0.00% -818.19% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 20.61% -0.43% 0.00% -1,030.02% 0.00% -28.23% 0.00% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for Marchex

This table displays calculated financial ratios and metrics derived from Marchex's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding		 43,364,575.00 43,316,764.00 43,658,595.00 43,678,595.00 43,682,345.00 43,682,345.00 43,714,230.00 43,901,730.00 44,178,980.00 43,906,261.00 43,910,198.00
DEI Adjusted Shares Outstanding		 43,364,575.00 43,316,764.00 43,658,595.00 43,678,595.00 43,682,345.00 43,682,345.00 43,714,230.00 43,901,730.00 44,178,980.00 43,906,261.00 43,910,198.00
DEI Earnings Per Adjusted Shares Outstanding		 -0.04 -0.03 -0.03 -0.02 -0.02 -0.04 -0.05 0.00 -0.02 -0.05 -0.04
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -3.18% 0.83% -5.26% -3.58% -1.76% -3.81% -1.48% -3.47% -8.28% -9.00% -6.88%
EBITDA Growth		 59.36% 84.31% 76.78% 97.08% 68.90% -117.38% -47.56% 1,309.80% -850.63% -106.40% 48.63%
EBIT Growth		 3.81% 68.17% 70.84% 73.25% 47.59% -41.57% -42.50% 25.76% -16.75% -49.72% 27.79%
NOPAT Growth		 17.45% 68.17% 70.84% 73.25% 37.50% -41.57% -42.50% -0.16% -14.06% -49.72% 27.79%
Net Income Growth		 0.71% 68.02% 67.61% 72.45% 46.28% -67.10% -36.69% 111.24% -22.74% -21.36% 13.02%
EPS Growth		 0.00% 92.59% 72.73% 66.67% 50.00% -100.00% -66.67% 100.00% 0.00% -25.00% 20.00%
Operating Cash Flow Growth		 62.28% 450.10% 43.44% 108.42% 201.06% -50.11% -5.81% 586.32% -24.08% -86.17% 80.40%
Free Cash Flow Firm Growth		 157.89% 194.25% 154.96% 204.37% -13.13% -82.01% -84.21% -59.30% -125.75% -778.15% 265.73%
Invested Capital Growth		 -7.86% -10.05% -7.74% -7.13% -6.45% -6.57% -6.43% -4.46% -1.89% 1.39% -7.12%
Revenue Q/Q Growth		 2.04% -3.01% -6.62% 4.33% 3.97% -5.03% -4.36% 2.22% -1.21% -5.78% -2.13%
EBITDA Q/Q Growth		 85.45% -47.24% -124.33% 93.92% -54.90% -929.11% -52.28% 149.84% -221.72% -123.44% 62.10%
EBIT Q/Q Growth		 43.02% 27.11% -17.13% 45.01% -11.63% -96.90% -17.90% 71.35% -75.56% -152.50% 43.14%
NOPAT Q/Q Growth		 51.09% 15.08% -17.13% 45.01% -14.27% -92.36% -17.90% 61.35% -30.12% -152.50% 43.14%
Net Income Q/Q Growth		 43.62% 26.12% -26.86% 47.86% -9.92% -129.84% -3.77% 104.29% -1,300.00% -127.25% 25.63%
EPS Q/Q Growth		 33.33% 50.00% -50.00% 33.33% 0.00% -100.00% -25.00% 100.00% 0.00% -150.00% 20.00%
Operating Cash Flow Q/Q Growth		 72.81% 564.02% -241.28% 104.72% 226.50% 129.06% -399.66% 130.63% -63.89% -58.28% -524.79%
Free Cash Flow Firm Q/Q Growth		 192.40% 46.57% -37.38% 23.06% -23.10% -69.64% -45.02% 217.09% -148.66% -699.42% 129.65%
Invested Capital Q/Q Growth		 -3.01% -9.74% 7.33% -1.16% -2.31% -9.85% 7.49% 0.93% 0.32% -6.84% -1.54%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 60.42% 62.22% 61.86% 65.61% 66.35% 63.24% 63.26% 65.10% 63.12% 61.18% 60.46%
EBITDA Margin		 -1.99% -3.02% -7.25% -0.42% -0.63% -6.82% -10.86% 5.29% -6.52% -15.47% -5.99%
Operating Margin		 -10.33% -9.04% -11.35% -5.98% -6.57% -13.31% -16.41% -4.60% -8.17% -21.90% -12.72%
EBIT Margin		 -12.04% -9.04% -11.35% -5.98% -6.42% -13.31% -16.41% -4.60% -8.17% -21.90% -12.72%
Profit (Net Income) Margin		 -12.11% -9.22% -12.53% -6.26% -6.62% -16.02% -17.38% 0.73% -8.86% -21.37% -16.24%
Tax Burden Percent		 100.59% 103.72% 104.24% 100.40% 103.10% 118.12% 105.76% 94.44% 102.72% 97.44% 113.05%
Interest Burden Percent		 100.00% 98.31% 105.94% 104.29% 100.00% 101.89% 100.16% -16.79% 105.53% 100.13% 112.88%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 5.56% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 -14.66% -14.08% -16.45% -8.72% -9.81% -21.80% -24.94% -9.36% -12.18% -34.81% -19.30%
ROIC Less NNEP Spread (ROIC-NNEP)		 -11.30% -12.03% -12.63% -6.80% -7.84% -15.97% -18.84% -14.62% -8.96% -29.04% -11.13%
Return on Net Nonoperating Assets (RNNOA)		 4.86% 5.28% 4.65% 2.43% 2.83% 6.38% 6.27% 4.94% 3.04% 10.52% 3.52%
Return on Equity (ROE)		 -9.81% -8.80% -11.80% -6.29% -6.97% -15.42% -18.66% -4.43% -9.15% -24.29% -15.79%
Cash Return on Invested Capital (CROIC)		 -26.15% -19.49% -10.94% -5.99% -5.56% -8.34% -9.22% -10.74% -13.92% -21.41% -10.30%
Operating Return on Assets (OROA)		 -10.90% -8.66% -11.47% -6.07% -6.70% -14.13% -18.25% -5.00% -8.92% -24.00% -14.35%
Return on Assets (ROA)		 -10.96% -8.83% -12.66% -6.35% -6.91% -17.00% -19.34% 0.79% -9.67% -23.42% -18.31%
Return on Common Equity (ROCE)		 -9.81% -8.80% -11.80% -6.29% -6.97% -15.42% -18.66% -4.43% -9.15% -24.29% -15.79%
Return on Equity Simple (ROE_SIMPLE)		 -33.11% 0.00% -19.75% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -0.92 -0.78 -0.92 -0.51 -0.58 -1.11 -1.31 -0.51 -0.66 -1.66 -0.95
NOPAT Margin		 -7.23% -6.33% -7.94% -4.19% -4.60% -9.32% -11.49% -4.34% -5.72% -15.33% -8.91%
Net Nonoperating Expense Percent (NNEP)		 -3.36% -2.04% -3.83% -1.92% -1.97% -5.84% -6.10% 5.26% -3.23% -5.77% -8.18%
Return On Investment Capital (ROIC_SIMPLE)		 - -2.19% -2.64% -1.46% -1.69% -3.40% -4.17% -1.58% -2.06% -5.53% -3.28%
Cost of Revenue to Revenue		 39.58% 37.78% 38.14% 34.39% 33.65% 36.76% 36.74% 34.90% 36.88% 38.82% 39.54%
SG&A Expenses to Revenue		 17.60% 22.54% 19.78% 20.94% 21.29% 23.11% 27.59% 21.08% 25.47% 20.91% 19.83%
R&D to Revenue		 30.85% 25.44% 28.04% 26.69% 24.74% 23.82% 23.43% 21.46% 20.58% 20.32% 22.67%
Operating Expenses to Revenue		 70.75% 71.26% 73.20% 71.59% 72.92% 76.56% 79.67% 69.70% 71.30% 83.08% 73.19%
Earnings before Interest and Taxes (EBIT)		 -1.54 -1.12 -1.31 -0.72 -0.81 -1.59 -1.87 -0.54 -0.94 -2.38 -1.35
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -0.25 -0.37 -0.84 -0.05 -0.08 -0.81 -1.24 0.62 -0.75 -1.68 -0.64
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 1.69 1.64 1.72 1.95 2.39 2.34 2.27 3.00 2.50 2.42 2.36
Price to Tangible Book Value (P/TBV)		 3.36 3.33 3.55 4.03 4.98 5.07 5.16 6.64 5.55 5.82 6.03
Price to Revenue (P/Rev)		 1.26 1.18 1.21 1.38 1.68 1.59 1.49 2.02 1.72 1.60 1.52
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 2.09 2.08 2.09 2.45 3.16 3.21 2.87 3.97 3.21 3.12 2.98
Enterprise Value to Revenue (EV/Rev)		 0.99 0.89 0.97 1.13 1.43 1.32 1.28 1.80 1.49 1.39 1.32
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 84.35
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 -0.43 -0.44 -0.37 -0.36 -0.36 -0.40 -0.33 -0.34 -0.34 -0.36 -0.32
Leverage Ratio		 1.28 1.30 1.29 1.32 1.30 1.32 1.30 1.31 1.29 1.32 1.31
Compound Leverage Factor		 1.28 1.28 1.37 1.38 1.30 1.35 1.30 -0.22 1.36 1.32 1.48
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 -4.68 -5.10 -5.23 -4.91 -3.98 -4.88 -5.31 -3.69 -4.58 -5.86 -6.53
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 2.44 2.45 2.49 2.37 2.52 2.40 2.50 2.42 2.53 2.36 2.22
Quick Ratio		 2.23 2.26 2.24 2.07 2.29 2.14 2.21 2.07 2.20 2.06 1.94
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 1.09 1.59 1.00 1.23 0.94 0.29 0.16 0.50 -0.24 -1.94 0.58
Operating Cash Flow to CapEx		 -18,900.00% 205.39% -61,950.00% 151.95% 208.74% 530.30% -907.27% 230.09% 75.92% 26.36% -116.03%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 12.77 39.54 0.00 0.00 52.43 0.00 -4.67 -646.73 3.31
Operating Cash Flow to Interest Expense		 0.00 0.00 -31.77 3.77 0.00 0.00 -874.00 0.00 5.58 40.33 -2.95
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 -31.82 1.29 0.00 0.00 -970.33 0.00 -1.77 -112.67 -5.50
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.91 0.96 1.01 1.01 1.04 1.06 1.11 1.09 1.09 1.10 1.13
Accounts Receivable Turnover		 6.01 6.32 6.09 6.36 6.12 6.65 6.10 6.26 6.14 6.61 6.20
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 13.93 15.48 14.88 14.95 18.06 22.87 25.15 26.43 24.54 24.79 24.16
Accounts Payable Turnover		 17.31 11.53 14.00 12.91 14.70 11.92 10.71 6.97 8.79 7.35 7.12
Days Sales Outstanding (DSO)		 60.71 57.74 59.98 57.42 59.68 54.86 59.86 58.35 59.49 55.22 58.92
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 21.08 31.66 26.08 28.27 24.83 30.63 34.09 52.39 41.50 49.65 51.30
Cash Conversion Cycle (CCC)		 39.63 26.08 33.90 29.15 34.86 24.23 25.77 5.96 17.99 5.57 7.62
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 24 21 23 23 22 20 21 22 22 20 20
Invested Capital Turnover		 2.03 2.22 2.07 2.08 2.13 2.34 2.17 2.16 2.13 2.27 2.17
Increase / (Decrease) in Invested Capital		 -2.01 -2.38 -1.92 -1.73 -1.52 -1.40 -1.47 -1.01 -0.42 0.28 -1.52
Enterprise Value (EV)		 49 44 48 55 70 64 61 86 69 63 59
Market Capitalization		 63 59 60 67 82 76 71 96 80 73 68
Book Value per Share		 $0.86 $0.83 $0.80 $0.79 $0.78 $0.75 $0.72 $0.73 $0.72 $0.69 $0.66
Tangible Book Value per Share		 $0.43 $0.41 $0.39 $0.38 $0.38 $0.35 $0.32 $0.33 $0.33 $0.29 $0.26
Total Capital		 37 36 35 35 34 33 31 32 32 30 29
Total Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 -14 -15 -12 -12 -12 -13 -10 -10 -10 -9.94 -9.02
Capital Expenditures (CapEx)		 0.00 0.85 0.00 0.08 0.18 0.17 0.29 0.35 0.38 0.46 0.44
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 0.43 -0.52 1.43 1.04 1.07 0.24 1.94 1.87 2.02 1.03 0.94
Debt-free Net Working Capital (DFNWC)		 14 14 13 13 13 13 12 12 12 11 9.96
Net Working Capital (NWC)		 14 14 13 13 13 13 12 12 12 11 9.96
Net Nonoperating Expense (NNE)		 0.62 0.36 0.53 0.25 0.25 0.80 0.67 -0.59 0.36 0.65 0.78
Net Nonoperating Obligations (NNO)		 -14 -15 -12 -12 -12 -13 -10 -10 -10 -9.94 -9.02
Total Depreciation and Amortization (D&A)		 1.28 0.75 0.47 0.67 0.73 0.77 0.63 1.15 0.19 0.70 0.72
Debt-free, Cash-free Net Working Capital to Revenue		 0.85% -1.04% 2.89% 2.13% 2.20% 0.51% 4.05% 3.94% 4.34% 2.27% 2.11%
Debt-free Net Working Capital to Revenue		 28.39% 28.22% 27.32% 26.67% 27.05% 27.04% 24.95% 26.01% 26.54% 24.16% 22.31%
Net Working Capital to Revenue		 28.39% 28.22% 27.32% 26.67% 27.05% 27.04% 24.95% 26.01% 26.54% 24.16% 22.31%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.04) ($0.02) ($0.03) ($0.02) ($0.02) ($0.04) ($0.05) $0.00 ($0.02) ($0.05) ($0.04)
Adjusted Weighted Average Basic Shares Outstanding		 42.76M 42.62M 43.05M 43.06M 43.20M 43.16M 43.72M 43.90M 43.91M 43.86M 43.96M
Adjusted Diluted Earnings per Share		 ($0.04) ($0.02) ($0.03) ($0.02) ($0.02) ($0.04) ($0.05) $0.00 ($0.02) ($0.05) ($0.04)
Adjusted Weighted Average Diluted Shares Outstanding		 47.43M 47.28M 47.72M 47.73M 47.86M 47.82M 48.38M 48.56M 48.57M 48.52M 48.62M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 43.32M 43.66M 43.68M 43.68M 43.68M 43.71M 43.90M 44.18M 43.91M 43.91M 44.30M
Normalized Net Operating Profit after Tax (NOPAT)		 -0.92 -0.78 -0.92 -0.51 -0.58 -1.11 -1.31 -0.51 -0.66 -1.66 -0.95
Normalized NOPAT Margin		 -7.23% -6.33% -7.94% -4.19% -4.60% -9.32% -11.49% -4.34% -5.72% -15.33% -8.91%
Pre Tax Income Margin		 -12.04% -8.89% -12.02% -6.24% -6.42% -13.56% -16.44% 0.77% -8.62% -21.93% -14.36%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 -16.83 -23.29 0.00 0.00 -623.67 0.00 -18.10 -792.00 -7.76
NOPAT to Interest Expense		 0.00 0.00 -11.78 -16.30 0.00 0.00 -436.57 0.00 -12.67 -554.40 -5.44
EBIT Less CapEx to Interest Expense		 0.00 0.00 -16.88 -25.77 0.00 0.00 -720.00 0.00 -25.44 -945.00 -10.31
NOPAT Less CapEx to Interest Expense		 0.00 0.00 -11.83 -18.79 0.00 0.00 -532.90 0.00 -20.01 -707.40 -7.98
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Marchex (NASDAQ: MCHX) is still operating in a tough spot, but there are a few signs of stabilization in the most recent quarter. In Q1 2026, revenue was $10.6 million, down modestly from $10.8 million in Q4 2025 and $11.5 million in Q3 2025. The company remains unprofitable, but the quarterly loss narrowed compared with the prior quarter. Cash flow was negative again, however cash on the balance sheet remains solid relative to its size.

Revenue trend: Over the last year, quarterly revenue has generally drifted lower from the low-$11 million to mid-$12 million range in 2024 to roughly $10.6 million in Q1 2026. That suggests Marchex has not yet returned to growth, and top-line pressure remains a concern.

Profitability trend: The company has continued to post operating losses in most quarters, but the trend improved somewhat in Q1 2026. Operating loss was $1.35 million versus $2.38 million in Q4 2025 and $0.94 million in Q3 2025, helped by lower total operating expenses. Net loss also improved to $1.7 million from $2.3 million in Q4 2025.

Cash flow trend: Q1 2026 operating cash flow was negative $514,000, compared with positive $121,000 in Q4 2025 and positive $290,000 in Q3 2025. That reversal is important for investors because it shows the business is not yet consistently self-funding its operations.

Balance sheet: Marchex ended Q1 2026 with $9.0 million in cash and equivalents, down from $10.3 million in Q3 2025 and $10.5 million in Q2 2025. Total current assets were $18.1 million versus current liabilities of $8.2 million, so near-term liquidity still looks manageable. Equity stood at $28.9 million.

  • Operating loss improved sharply in Q1 2026 versus Q4 2025, suggesting some expense discipline or margin recovery.
  • Net loss narrowed to $1.7 million from $2.3 million in the prior quarter.
  • Cash and equivalents of $9.0 million provide a cushion for ongoing operations.
  • Current assets exceeded current liabilities, indicating the company still has short-term liquidity flexibility.
  • Revenue was relatively stable quarter over quarter, but the broader trend over the last year has been slightly down.
  • Share count has been fairly steady, with no major dilution trend visible in the recent quarters.
  • Operating cash flow turned negative again in Q1 2026 after two better quarters.
  • Revenue has not shown sustained growth since early 2024, limiting the case for a fundamental turnaround.
  • The company remains loss-making on both operating and net income bases.
  • Goodwill remains a large asset relative to total assets, which can be a risk if future performance weakens.

Bottom line: Marchex is showing some improvement on the expense and loss side, but the core investment question remains whether it can restore durable revenue growth and consistently positive operating cash flow. Until that happens, the stock likely remains a turnaround story rather than a steady growth name.

07/21/26 12:10 AM ETAI Generated. May Contain Errors.

Marchex Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Marchex's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Marchex's net income appears to be on a downward trend, with a most recent value of -$5.24 million in 2025, falling from $26.72 million in 2015. The previous period was -$4.95 million in 2024. See Marchex's forecast for analyst expectations on what's next for the company.

Marchex's total operating income in 2025 was -$5.72 million, based on the following breakdown:
  • Total Gross Profit: $28.71 million
  • Total Operating Expenses: $34.43 million

Over the last 10 years, Marchex's total revenue changed from $143.01 million in 2015 to $45.42 million in 2025, a change of -68.2%.

Marchex's total liabilities were at $9.60 million at the end of 2025, a 9.2% decrease from 2024, and a 45.3% decrease since 2015.

In the past 10 years, Marchex's cash and equivalents has ranged from $9.94 million in 2025 to $109.16 million in 2015, and is currently $9.94 million as of their latest financial filing in 2025.

Over the last 10 years, Marchex's book value per share changed from 4.45 in 2015 to 0.69 in 2025, a change of -84.6%.


Related Companies

Financial statements for NASDAQ:MCHX last updated on 7/16/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
Sam Altman backs small company that could save U.S. power grid
A small Colorado company holds the rights to technology that could protect the U.S. public power grid from col...
Altimetry | Sponsoredtc pixel
BlackRock is hoarding it. JPMorgan is hoarding it. Do you own it?
BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...
Awesomely | Sponsoredtc pixel
Man who Predicted Trump 2016 Win: “Prepare for Mid-Term Meltdown”
In 2016, major election models gave Hillary Clinton a 99% chance of winning - but former CIA and Pentagon advi...
Paradigm Press | Sponsoredtc pixel
Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...
Profits Run | Sponsoredtc pixel
I found Rolls-Royce at $2 - now I see the same setup again
In 2022, Karim Rahemtulla recommended Rolls-Royce under $2 - a misunderstood aerospace name the market had wri...
Monument Traders Alliance | Sponsoredtc pixel
Your withdrawal order could cost you in taxes
If you have $2M or more saved, the 4% rule points to roughly $92,000 a year - but it's a single-variable answe...
SmartAsset | Sponsoredtc pixel
Trump’s emergency dollar reset
Bloomberg research shows the U.S. dollar's share of global reserves has fallen to the lowest level this centur...
Porter & Company | Sponsoredtc pixel
It’s one of Trump’s biggest holdings. Do you own it?
President Trump holds up to $5 million in shares of an AI company that just landed a nearly $10 billion Pentag...
InvestorPlace | Sponsoredtc pixel